Harrow HROW
NASDAQ HROW
$37.74 -0.10 (-0.28%)
As of: Sep 9, 2026 · 12:53 PM EDT

Harrow (HROW) Income towards Parent Company (2010 - 2026)

Harrow (HROW) posted Income towards Parent Company of -$17.3 million for Q2 2026, up 37.43% on a QoQ basis from -$27.6 million in Q1 2026, and down 445.75% year-over-year from $5.0 million in Q2 2025.

Analysis

Harrow (HROW) Income towards Parent Company (2010 - 2026) Analysis & Trends

Harrow has reported Income towards Parent Company for 17 years, with the latest figure at -$17.3 million in Q2 2026.

  • On a quarterly basis, Income towards Parent Company fell 445.75% year-over-year to -$17.3 million in Q2 2026; TTM through Jun 2026 was -$33.5 million, a 227.09% decrease from a year earlier, with the FY2025 full-year figure at -$5.1 million, up 70.6% from the prior year.
  • Income towards Parent Company was -$17.3 million for Q2 2026 at Harrow, up from -$27.6 million in the prior quarter.
  • The five-year high for Income towards Parent Company was $10.4 million in Q4 2025, with the low at -$27.6 million in Q1 2026.
  • Average Income towards Parent Company over 5 years is -$5.7 million, with a median of -$5.3 million recorded in 2022.
  • The sharpest annual moves came in 2022 and 2025: Income towards Parent Company tumbled 1223.5% in 2022, then jumped 177.17% in 2025.
  • Over 5 years, Income towards Parent Company stood at $1.1 million in 2022, then sank by 967.11% to -$9.1 million in 2023, then soared by 174.08% to $6.8 million in 2024, then soared by 53.42% to $10.4 million in 2025, then plunged by 266.11% to -$17.3 million in 2026.
  • The last three Income towards Parent Company figures came in at -$17.3 million (Q2 2026), -$27.6 million (Q1 2026), and $10.4 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 642.70 Bn 621.95 Bn 17.26 Bn
2 AbbVie 440.80 Bn 434.23 Bn 12.70 Bn
3 Merck 364.74 Bn 357.60 Bn 12.21 Bn
4 Novartis Ag 266.37 Bn 258.68 Bn 11.24 Bn
5 Pfizer 158.89 Bn 147.19 Bn 10.94 Bn
6 Sanofi 52.43 Bn 45.05 Bn 10.79 Bn
7 Revolution Medicines 44.38 Bn 44.38 Bn -
8 Incyte 25.28 Bn 20.74 Bn 1.57 Bn
9 United Therapeutics 21.46 Bn 18.80 Bn 683.80 Mn
10 Harrow 1.41 Bn 1.32 Bn 50.36 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -17.27 Mn
Mar 31, 2026 -27.60 Mn
Dec 31, 2025 10.40 Mn
Sep 30, 2025 1.02 Mn
Jun 30, 2025 5.00 Mn
Mar 31, 2025 -17.78 Mn
Dec 31, 2024 6.78 Mn
Sep 30, 2024 -4.22 Mn
Jun 30, 2024 -6.47 Mn
Mar 31, 2024 -13.57 Mn
Dec 31, 2023 -9.15 Mn
Sep 30, 2023 -4.39 Mn
Jun 30, 2023 -4.23 Mn
Mar 31, 2023 -6.64 Mn
Dec 31, 2022 1.06 Mn
Sep 30, 2022 -6.46 Mn
Jun 30, 2022 -6.24 Mn
Mar 31, 2022 -2.44 Mn
Dec 31, 2021 -7.29 Mn
Sep 30, 2021 -8.33 Mn